T oxic and cholestatic liver injury is characterized by the activation and release of a variety of proinflammatory cytokines. 1, 2 In this contribution, tumor necrosis factor ␣ (TNF-␣), interleukin 1␤ (IL-1␤), and IL-6 are produced by macrophages, including resident hepatic Kupffer cells, and lead to local amplification and prolongation of defensive mechanisms by the damaged liver. 2 Experimental lipopolysaccharide (LPS) challenge leads to an elevated secretion of TNF-␣, IL-1␤, and IL-6 within 6 hours from either human or rodent liver. 3, 4 Similarly, TNF-␣ and IL-1␤ appear to be elevated after bile duct ligation due to the cholestatic condition, whereas IL-6 levels are only shortly increased as a phasic response to surgical trauma. 2, 4 Elevated TNF-␣ levels also occur in various other forms of liver injury, including alcoholic hepatitis in humans and experimental toxic liver injury induced by carbon tetrachloride in rats. 1, 5 In contrast to cholestatic injury, elevations of serum TNF-␣ levels predominate within the first 12 hours of acute CCl 4 -induced toxic liver injury, whereas serum IL-1␤ levels appear to be significantly elevated not until 24 hours after treatment. 6 In vitro and in vivo studies have shown that inflammatory stimulation with either endotoxin or isolated cytokines such as TNF-␣, IL-1␤, and IL-6 decreases uptake and secretion of biliary constituents. [7] [8] [9] [10] Studies in both LPS-and CCl 4 -treated rats documented a decrease in bile flow to various extents [11] [12] [13] [14] [15] [16] and a reduced plasma clearance or uptake of various organic anions, including sulfobromophthalein and indocyanine green. 11, 14, 17 Physiologically, organic anions are taken up from portal blood by a sodium-dependent taurocholate cotransporter (Ntcp/Slc10a1) and several members of a growing family of sodium-independent organic anion transporters (Oatp1/Slc21a1, Oatp2/Slc21a5, Oatp4/Slc21a10). 18 After rapid transhepatic transport to the canalicular membrane, organic anions are secreted into bile by 2 adenosine triphosphate-dependent export pumps: the bile salt export pump (Bsep/Abcb11) and the multidrug resistance protein 2 (Mrp2/Abcc2). 18 Molecular studies in animal models of cholestasis induced by either endotoxin or bile duct ligation indicate a down-regulation of organic anion transporters at both the basolateral and canalicular membrane, 10, [19] [20] [21] [22] [23] whereas toxic liver injury induced by CCl 4 leads to a selective down-regulation of organic anion transporters at the basolateral domain. 24 However, the cytokine-mediated mechanisms underlying the differential transcriptional regulation of basolateral hepatocellular transport systems during both toxic and cholestatic liver injury in vivo still remain to be elucidated. TNF-␣ has been shown to inhibit sodiumdependent taurocholate uptake by hepatocytes. 8, 9 Subsequently, one study investigating the effect of isolated cytokines on transporter expression identified TNF-␣ and IL-1␤ as mediators of decreased Ntcp messenger RNA (mRNA) expression, whereas treatment with IL-6 had no significant effect on Ntcp mRNA. 10 In regard to Mrp2, both cytokines have been shown to mediate mRNA down-regulation with significant TNF-␣ effects only when used in higher doses. 25 IL-1␤ has been shown in vitro to decrease both basolateral Ntcp and canalicular Mrp2 promoter activity in parallel due to reduced nuclear levels of transactivating retinoid X receptor/retinoic acid receptor (RXR␣/RAR␣) heterodimers in transfected HepG2 cells, whereas TNF-␣ has been shown to selectively affect basolateral Ntcp promoter activity. 26 This observation led to the hypothesis that IL-1␤, which is produced in cholestasis induced by endotoxin together with TNF-␣, leads to a down-regulation of both basolateral Ntcp and canalicular Mrp2 putatively by decreased nuclear levels of RXR␣/RAR␣. In contrast, CCl 4 preferentially induces TNF-␣ production in its early phase, which has been postulated to affect the basolateral Ntcp by decreased binding activity of hepatocyte nuclear factor 1␣ (HNF-1␣). 24 The differential expression of Mrp2 between these 2 models has been attributed to the unchanged activity of the RXR␣/RAR␣ complex in the CCl 4 model. 24 The aim of the present study was to determine the differential effects of TNF-␣ and IL-1␤ on transporter mRNA expression and transactivators of hepatic transporter genes by inactivation of either cytokine in animal models of toxic and cholestatic liver injury.
Materials and Methods
Animal Models. Toxic and cholestatic liver injury were induced in male Sprague-Dawley rats (250-300 g; n ϭ 4) by intraperitoneal injection of either CCl 4 (1:1 with corn oil, 2 mL/kg) or Salmonella typhimurium LPS (1 g/kg in 0.9% NaCl) as previously described. 23, 24 Inactivation of TNF-␣ and IL-1␤ was performed in both treatment groups by repetitive intraperitoneal injection of either etanercept (1-8 mg/kg, 16 hours and 1 hour before CCl 4 or LPS) or anakinra (10-300 g/kg, every 6 hours for 24 hours before and after CCl 4 or LPS; kindly provided by Amgen Inc., Thousand Oaks, CA). Control animals received either corn oil (in case of CCl 4 treatment) or saline (in case of LPS) and human albumin at the same time points. Livers were harvested after 24 hours and 20 hours, respectively. Study protocols were approved by the Animal Care Committee of the federal government. All animals received humane care according to the criteria outlined in the Guide for the Care and Use of Laboratory Animals prepared by the National Academy of Sciences.
Northern Analysis. RNA was isolated from liver by standard phenol chloroform extraction procedure. Total RNA (10-20 g) was analyzed by Northern blotting with specific and constitutively expressed probes of Ntcp, Oatp1, Oatp2, Mrp2, and glyceraldehyde-3-phosphate dehydrogenase as previously described. 27 Electrophoretic Mobility Shift Analysis. A total of 5 to 10 g of nuclear extracts (protein) was incubated on ice for 30 minutes with 2 ϫ 10 4 cpm [ 32 P] end-labeled oligonucleotide probes representing either binding sites for RXR/RAR (DR-1), HNF1, CAAT enhancer binding protein (C/EBP), and DR-3 as well as ER-8 consensus sequences for pregnane X receptor (PXR) and constitutive androstane receptor (CAR) as previously described. [28] [29] [30] [31] For competition assays, 100-fold molar excess of unlabeled oligonucleotides was coincubated with the labeled probe. Separation of protein-DNA complexes from unbound labeled probes was performed by electrophoresis through a nondenaturing 6% polyacrylamide gel and quantified by phosphoimaging (BioRad, Munich, Germany).
Western Analysis. Preparation of nuclear extracts was performed as previously described 29 
Results
Effects of Cytokine Inactivation on Steady-State mRNA Levels in Toxic Liver Injury. To determine whether reduced expression of basolateral transporters Ntcp, Oatp1, and Oatp2 after treatment with CCl 4 24 was prevented by inactivation of either TNF-␣ or IL-1␤, we quantified their steady-state mRNA levels by Northern analysis (Fig. 1) . In CCl 4 -treated animals without anticytokine treatment, down-regulation was observed for Ntcp, Oatp1, and Oatp2, which declined to 5% Ϯ 3%, 10% Ϯ 3%, and 5% Ϯ 2% of untreated controls, respectively (P Ͻ .05; n ϭ 4) (Fig. 1) . The extent of downregulation observed in this study (all rats with ␥-glutamyltransferase levels Ͼ300 U/L) is comparable with previous results observed in CCl 4 -treated rats with higher ␥-glutamyltransferase levels. 24 Inactivation of TNF-␣ by pretreatment with etanercept over a range from 1 to 8 mg/kg showed a dose-dependent recovery of steady-state mRNA levels of Ntcp, Oatp1, and Oatp2 with levels at 8 mg/kg similar to baseline (113% Ϯ 24%, 75% Ϯ 5%, and 86% Ϯ 21% of controls, respectively) ( Fig. 1) . In contrast, inactivation of IL-1␤ with increasing doses of anakinra up to 300 g/kg only led to a partial preservation of Ntcp and both Oatp mRNAs to 66% Ϯ 19%, 50% Ϯ 10%, and 48% Ϯ 13% of controls, respectively (P Ͻ .05; n ϭ 4) (Fig. 1) . However, maximum preservation was already obtained at 100 g/kg with no further effect when a dose of 300 g/kg anakinra was applied.
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Effects of Cytokine Inactivation on Binding Activity and Nuclear Protein Mass of Transcription Factors in Toxic Liver Injury. Electrophoretic mobility shift analysis was performed to further elucidate the mechanisms by which inactivation of TNF-␣ or IL-1␤ prevents CCl 4 -induced down-regulation of basolateral organic anion transporters. Of those, Ntcp and Oatp2 represent basolateral organic anion transporter genes, for which promoter sequences have been cloned and regulators assigned. 29, 34 Thus, oligonucleotides were used representing binding sites for Ntcp and Oatp2 transactivators including HNF1 and C/EBP as well as a DR-3 element with a known binding site for PXR and CAR 23, 26, [34] [35] [36] ( Fig. 2) . Binding of nuclear extracts to an RXR/RAR responsive element has previously been found to be unaffected by CCl 4 treatment. 24 Analysis of nuclear extracts isolated 24 hours after CCl 4 showed an absent binding activity of HNF1, C/EBP, and PXR/CAR (lanes 3 and 4, Fig. 2A and B) . Decreased binding activity of HNF1 was partially prevented by pretreatment with etanercept (51% Ϯ 8% of controls, P Ͻ .05), whereas C/EBP and PXR/ CAR binding remained suppressed (14% Ϯ 1% and 12% Ϯ 3% of controls, respectively) ( Fig. 2A [lanes 5-7] and B). In contrast, HNF1, C/EBP, and PXR/CAR binding still declined despite IL-1␤ inactivation by anakinra (11% Ϯ 3%, 19% Ϯ 4%, and 22% Ϯ 5% of controls, respectively) ( Fig. 2A [lanes 8-10] and B). Nuclear protein content of RXR␣, PXR, or CAR was not significantly changed in all treatment groups when analyzed by Western blotting (Fig. 3) . Thus, diminished nuclear availability of these heterodimeric partners is not responsible for decreased binding activity. Effects of Cytokine Inactivation on Steady-State mRNA Levels in Cholestatic Liver Injury. To further investigate whether reduced expression of basolateral Ntcp and canalicular Mrp2 in endotoxin-induced cholestasis 20, 23 can also be prevented by inactivation of TNF-␣ or IL-1␤, we subsequently quantified their steady-state mRNA levels after treatment with LPS in the absence or presence of anticytokines (Fig. 4) . In LPStreated controls, basolateral Ntcp, Oatp1, Oatp2, and canalicular Mrp2 mRNA levels declined to 9% Ϯ 5%, 21% Ϯ 14%, 12% Ϯ 5%, and 21% Ϯ 6% of controls, respectively (P Ͻ .05; n ϭ 4) (Fig. 4) . Inactivation of TNF-␣ by pretreatment with etanercept did not affect steady-state mRNA levels of Ntcp, Oatp1, Oatp2, or Mrp2 (Fig. 4) . In contrast, inactivation of IL-1␤ with increasing doses of anakinra resulted in partially maintained mRNA levels of Ntcp and full preservation of Mrp2 (37% Ϯ 8% and 71% Ϯ 26% of controls, respectively), whereas Oatp1 and Oatp2 remained largely unchanged (P Ͻ .05; n ϭ 4) (Fig. 4) .
Effects of Cytokine Inactivation on Binding Activity of Transcription Factors in Cholestatic Liver Injury. Electrophoretic mobility shift analysis was also performed with nuclei from LPS-treated animals and oligonucleotides representing binding sites for Ntcp, Oatp2, and Mrp2 transactivators 23, 26, 31, 34, 35 to further elucidate the mechanisms by which inactivation of IL-1␤ prevents down-regulation of basolateral and canalicular organic anion transporters (Fig. 5) . In addition to HNF1 and C/EBP, 3 different canonical DNA elements (DR-1, DR-3, and ER-8) were used as previously shown to bind RXR heterodimers of various class II nuclear receptors, including RAR, PXR, and CAR. 23, 30, 31, 35, 36 Binding of HNF1 and C/EBP was maintained by inactivation of both TNF-␣ (105% Ϯ 25% and 88% Ϯ 10%, respectively, P Ͻ .05) and IL-1␤ (110% Ϯ 63% and 56% Ϯ 24%, respectively, P Ͻ .05) (Fig. 5) . In contrast, RXR/ RAR activity was only partially preserved by either TNF-␣ (31% Ϯ 21%) or IL-1␤ inactivation (38% Ϯ 9%, P Ͻ .05), whereas binding activity to 2 different PXR-and CAR-responsive elements (DR-3, ER-8) remained largely unaffected by either anticytokine treatment (Fig. 5) .
Effects of Cytokine Inactivation on Nuclear Protein Mass of Transcription Factors in Cholestatic Liver
Injury. To further investigate whether reduced binding activity was associated with diminished nuclear protein levels of RXR␣, PXR, or CAR, we performed Western blotting of nuclear extracts (Fig. 6 ). Protein levels of these nuclear receptors decreased in general by 50% after LPS treatment (P Ͻ .05) and could not be preserved by either form of cytokine inactivation. In case of CAR and PXR, TNF-␣ inactivation even further decreased nuclear protein mass to 20% Ϯ 2% and 28% Ϯ 31% (P Ͻ .05) (Fig. 6) . Liver Histology and Clinical Chemistry. To exclude unspecific changes in transporter expression and activity of their nuclear regulators, liver histology and clinical chemistry were analyzed in all CCl 4 and LPS treatment groups. Liver injury in CCl 4 -treated animals was confined to the pericentral region, affecting a maximum of 30% to 50% of all hepatocytes (Fig. 7B) . Neither etanercept nor anakinra prevented CCl 4 -induced liver injury, but both anticytokines ameliorated the degree of its toxic effect. In rats treated with CCl 4 alone, necrosis and vacuolic degeneration occurred in the pericentral region (Fig. 7C) , whereas necrosis was absent in animals with administration of either anticytokine ( Fig. 7D and E) . However, vacuolic degeneration as a marker of liver injury was still present in all animals treated with anticytokines, irrespective of the type of cytokine inactivator ( Fig. 7D and E) . Changes in histology were accompanied by less elevated alanine aminotransferase levels (Table 1 ). In LPS-treated animals with and without anticytokine treatment, neither treatment resulted in any alterations of liver histology (not shown) or liver function tests (Table 1) .
Discussion
The present study supports the common concept that proinflammatory cytokines are important regulators of organic anion transporters. 10, 23, 25, 26 Inactivation of either TNF-␣ or IL-1␤ leads to a complete or at least partial recovery of these transporters in 2 different models of liver injury. However, the effects of TNF-␣ and IL-1␤ are not uniform but rather differently affect transporter expression in animal models of toxic liver injury by CCl 4 -and LPS-induced cholestasis. The data also suggest that TNF-␣-and IL-1␤-independent signals significantly participate, especially in the LPS-mediated down-regulation of various transporter genes.
In CCl 4 -induced liver injury, TNF-␣ might have a gatekeeper function as the master cytokine, because its inactivation by etanercept fully prevents a decline of mRNA levels of Ntcp, Oatp1, and Oatp2 (Fig. 1) . IL-1␤ is also involved in CCl 4 -mediated down-regulation but plays a minor role, probably as a downstream effector, because inactivation by anakinra only leads to a partial preservation of basolateral transporter expression by 50% to 70% of controls (Fig. 1) . Although liver damage is ameliorated compared with animals treated with CCl 4 alone, effects of anticytokine treatment on transporter regulation appear to be specific because neither etanercept nor anakinra prevent toxic liver injury (Fig. 7) .
Because the repression of organic anion transporters is believed to occur primarily at the transcriptional level, we determined the binding activity and nuclear protein levels of their known transactivators such as HNF1, C/EBP, PXR, and CAR 23, 26, 34, 35 in CCl 4 -induced liver injury (Fig. 2) . Decreased binding activity of HNF1 was partially prevented by TNF-␣ and to an even lesser extent by IL-1␤ inactivation, whereas C/EBP, PXR, and CAR binding remained suppressed by either treatment (Fig. 2) . Binding to an RXR/RAR cis-acting element has previously been reported to be unaffected by CCl 4 treatment, 24 which is in line with maintained nuclear protein mass of RXR␣ as its heterodimeric partner of RAR␣ (Fig. 3) . These data support the hypothesis that down-regulation of basolateral organic anion transporters, including Ntcp, Oatp1, and Oatp2, in CCl 4 -treated animals may occur by a TNF-␣-induced decrease of HNF1 binding activity. In case of rat Ntcp and Oatp2, HNF1 binding sites are located in the 5Ј-flanking region 23, 34 and HNF1␣ has been assigned as a major regulator of Ntcp gene activity. 26 The 5Ј-flanking region of the rat Oatp1 gene has not been cloned to date. However, our data suggest a central role for HNF1 not only as a regulator of rat Ntcp but also of rat Oatp1 and Oatp2 and are in close agreement with the dramatically decreased expression levels of these 3 transporters in HNF1 Ϫ/Ϫ mice. 37 In the CCl 4 model, HNF1 appears in vivo as the main regulator of the rat Ntcp gene because its down-regulation occurs in the absence of HNF1 but maintained RXR/RAR binding activity and RXR␣ nuclear protein mass (Fig. 3) . In line with data obtained in HNF1 Ϫ/Ϫ mice, 37 our study indicates that HNF1 also represents a transactivator of basal Oatp2 gene expression. Rat Oatp2 can be activated by PXR-and CAR-dependent mechanisms, which seem to act primarily as an inducer in response to taurolithocholic acid and certain chemicals but are not required for Oatp2 basal expression, at least in PXR Ϫ/Ϫ mice. 35, [38] [39] [40] In CCl 4 -induced liver injury, both transactivators do not play an important role, because decreased binding activity cannot be prevented by either anticytokine treatment (Fig. 2) even in the presence of maintained nuclear protein content of PXR and CAR in all treatment groups, including CCl 4 alone (Fig. 3) .
In endotoxin-induced cholestasis, expression of organic anion transporters seems to be regulated by multiple cytokine-mediated signal transduction pathways because neither cytokine acts as a gatekeeper in activation of the cytokine cascade. Inactivation of TNF-␣ did not prevent the known down-regulation of basolateral and canalicular transporters in endotoxin-treated rats at all. In contrast, blockage of IL-1␤ activity fully preserved Mrp2 mRNA expression, whereas Ntcp was partially maintained at 40% of control levels (Fig. 4) . However, mRNA reduction of Oatp1 and Oapt2 was not affected by either anticytokine (Fig. 4) . In endotoxemia, binding of LPS to the toll-like receptor 4 simultaneously induces a broad spectrum of proinflammatory cytokines, including TNF-␣ and IL-1␤, which then act to amplify the inflammatory signals through binding to specific receptors. 41 However, direct effects of LPS on downstream signals such as nuclear factor B have been described without activation of TNF or IL-1. 41, 42 Thus, our findings in endotoxemia indicate that down-regulation of basolateral organic anion transporters does not depend on single cytokines alone and may involve TNF-␣-and IL-1␤-independent signal transduction pathways. In contrast, regulation of the canalicular Mrp2 solely depends on IL-1␤-mediated signal amplification in endotoxemia, because inactivation of IL-1␤, but not TNF-␣, fully prevents the known decline in Mrp2 mRNA (Fig. 4) .
Whereas the effect of cytokine inactivation on Ntcp and Mrp2 expression in LPS-induced cholestasis is in line with previous studies, 10, 20, [23] [24] [25] their molecular regulation in vivo appears to be more complex than indicated by in vivo and in vitro studies. 23, 26, 43 In these studies, HNF1 binding activity declined before reduction of Ntcp mRNA after LPS, 23 whereas RXR/RAR has been shown in vitro to mediate IL-1␤-induced down-regulation of the Ntcp and Mrp2 genes. 23, 26 In our study, HNF1, C/EBP, and at least in part RXR/RAR binding activity is restored by both TNF-␣ and IL-1␤ inactivation but only anti-IL-1␤ results in partial preservation of Ntcp mRNA (Fig. 5) . Compared with the CCl 4 model, which fits with HNF1 as a major regulator of the Ntcp gene, the findings in LPS-treated animals with maintained binding activity of HNF1 by both anticytokines but absent Ntcp expression after administration of etanercept seems to argue against its central role in Ntcp gene regulation. However, our data are not contradictory to the concept that HNF1 represents an important regulator of basolateral transporters in general, because binding activity of HNF1 to its consensus sequence does not necessarily resemble transcriptional activation of the corresponding gene. In case of HNF1, this may require synergism between multiple coactivator proteins or even corepressors. 44, 45 However, even efficient recruitment of coactivators into the promoter may not be sufficient to induce transcription because they do not represent constitutively active proteins but rather may require an active configuration as a result of their interaction with DNA binding proteins. 45 Certain coactivators of HNF1 such as CREB binding protein and CREB binding protein-associated factor also express histone acetyltransferase activity, which may be modulated by systemic inflammation after LPS, thus preventing localized remodeling of chromatin necessary for the accessibility of transcription factors such as HNF1 to the nucleosomal DNA. Thus, this complex transcription machinery in vivo may be preserved by anti-IL-1␤ treatment but not in all necessary components by TNF blockade despite maintained HNF1 binding activity in the electrophoretic mobility shift analysis. Alternatively, the ratio between HNF1 ␣ and ␤ isoforms may be important as previously shown for the regulation of the sucroseisomaltase gene, 46 but this mechanism could be excluded by a maintained ratio of HNF1␣/HNF1␤ in supershift assays with nuclear extracts from LPS/anticytokinetreated rats (Geier et al., unpublished data, January 2003). Nevertheless, the molecular mechanisms by which LPS affects HNF1 activity remain to be determined in detail.
In addition, RXR/RAR has been identified as an important transactivator of the Ntcp and Mrp2 genes. 23, 24, 26, 47 IL-1␤-dependent down-regulation of RXR/RAR nuclear protein levels and binding activity has recently been associated with decreased Mrp2 expression in HepG2 cells and primary rat hepatocytes and in rats with obstructive cholestasis. 26, 43, 47 However, its partially maintained binding after LPS to a similar extent by either anticytokine treatment neither explains the partially maintained Ntcp nor the fully preserved Mrp2 mRNA expression only by anti-IL-1␤ but not anti-TNF-␣ treatment (Fig. 4) . In LPS-treated rodents, reduced RXR/ RAR activity has been attributed to reduced RXR␣ protein levels as well as RXR and RAR mRNA levels in hamsters and mice. 48, 49 RXR␣ nuclear protein levels are also decreased in the present study but do not recover by either anticytokine treatment (Fig. 6) . Thus, diminished availability of RXR␣ as a mandatory heterodimerization partner of RAR␣ is consistent with decreased binding activity of RXR/RAR even after IL-1␤ or TNF-␣ inactivation (Fig. 5) . Furthermore, these data indicate that RXR/RAR in vivo may not be of biological importance in Ntcp and Mrp2 regulation as expected from the in vitro studies.
To further determine the molecular mechanism by which IL-1␤ suppresses gene transcription, other candidate transactivators of the Mrp2 gene, including FXR, PXR, and CAR, 31 have been studied. Decreased PXR and CAR mRNA levels have been reported in LPS-treated mice, 49 indicating that, in addition to diminished RXR levels, reduced nuclear availability of these receptors might also account for reduced Mrp2 expression. However, neither their binding activity at the Mrp2 ER-8 element nor the nuclear receptor levels of PXR and CAR are preserved by IL-1␤ inactivation (Figs. 5 and 6 ). Thus, our data exclude a functional relevance of these transactivators in Mrp2 gene expression in endotoxemia but suggest that additional, thus far unknown IL-1␤-dependent transcription factors play an important role in Mrp2 gene regulation.
In summary, we determined the influence of TNF-␣ and IL-1␤ on the in vivo regulation of organic anion transporters following toxic or cholestatic liver injury. In CCl 4 toxic liver injury, TNF-␣ represents the master cytokine responsible for down-regulation of basolateral Ntcp, Oatp1, and Oatp2, probably by HNF1-dependent mechanisms. In contrast, IL-1␤ predominates a far more complex signaling network in endotoxin-mediated cholestasis with full preservation of canalicular Mrp2 and partial maintenance of Ntcp expression after selective IL-1␤ inactivation. In endotoxemia, additional signal transduction pathways are involved in down-regulation of the basolateral Oatp1 and Oatp2 and in part Ntcp, which do not depend on amplification of the inflammatory signals by either TNF-␣ or IL-1␤. Although transactivators such as HNF1 and RXR/RAR have been identified in vitro as important regulators of organic transporters genes, their particular role in cytokine-mediated regulation in vivo still remains to be determined. However, understanding of these regulatory pathways in vivo represents a mandatory prerequisite for any future therapeutic intervention in acute or chronic liver diseases.
